25
Participants
Start Date
November 30, 2005
Primary Completion Date
July 31, 2008
Study Completion Date
July 31, 2008
TroVax
TroVax 1 x 10E9 TCID 50mL
IL-2
IL-2 250,000 U/kg S/C for cycle 1 and day 1 of subsequent cycles, 125,000U/kg S/C for days 2-5 of cycles 2-6
The Methodist Hospital, Houston
Lead Sponsor
Collaborators (1)
The Methodist Hospital Research Institute
OTHER
ORION Clinical Services
INDUSTRY
Oxford BioMedica
INDUSTRY